A claim for caution in the use of promising bumetanide to treat neonatal seizures

Journal of Child Neurology

Volumn 26, Issue 5, 2011, Pages 557-558

  Nsimire Chabwine, Joelle ^a   Vanden Eijnden, Serge ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BUMETANIDE; PHENOBARBITAL; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; LOOP DIURETIC AGENT;

ADD ON THERAPY; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; DIURESIS; DRUG PENETRATION; HUMAN; LETTER; NEONATAL SEIZURE; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; INFANT; NOTE;

BUMETANIDE; HUMANS; INFANT; SEIZURES; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 80052060305     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811401395     Document Type: Letter

References (11)

1. Kahle KT, Barnett SM, Sassower KC, Staley KJ Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol. 2009 ; 24: 572-576.
2. Ben Ari Y., Gaiarsa JL, Tyzio R., Khazipov R. GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev. 2007 ; 87: 1215-1284. (Pubitemid 350041471)
3. DzhalaVI, TalosDM, SdrullaDA, etal. NKCC1transporterfacilitates seizures in the developing brain. Nat Med. 2005 ; 11: 1205-1213.
4. Vanhatalo S., Hellström-Westas L., De Vries LS Bumetanide for neonatal seizures: based on evidence or enthusiasm? Epilepsia. 2009 ; 50: 1292-1293.
5. Lopez-Samblas AM, Adams JA, Goldberg RN, Modi MW The pharmacokinetics of bumetanide in the newborn infant. Biol Neonat. 1997 ; 72: 265-272. (Pubitemid 27480416)
6. Javaheri S., Davis C., Rogers DH Ionic composition of cisternal CSF in acute respiratory acidosis: lack of effect of large dose bumetanide. J Neurochem. 1993 ; 61: 1525-1529. (Pubitemid 23285113)
7. Zimmermann A., Domoki F., Bari F. Seizure-induced alterations in cerebrovacular function in the neonate. Dev Neurosci. 2008 ; 30: 293-305.
8. Merkus Fwhm, van den Berg MP Can nasal drug delivery bypass the blood-brain barrier? Questioning the direct transport theory. Drugs R D. 2007 ; 8: 133-144. (Pubitemid 46707837)
9. Chabwine JN, Talavera K., Verbeert L., et al. Differential contribution of the Na+-K+-2Cl- cotransporter to chloride handling in rat embryonic dorsal root ganglion neurons and motor neurons. FASEB J. 2009 ; 23: 1168-1176.
10. Viberg H., Ponten E., Eriksson P., Gordh T., et al. Neonatal ketamine exposure results in changes in biochemical substrates of neuronal growth and synaptogenesis, and alters adult behavior irreversibly. Toxicology. 2008 ; 249: 153-159.
11. Gonzalez FF, Ferriero DM Therapeutics for neonatal brain injury. Pharmacol Ther. 2008 ; 120: 43-53.